Scientists have made a groundbreaking breakthrough in the fight against classical swine fever, a devastating viral disease that has ravaged pig farming worldwide for decades. A team of researchers at Edinburgh's Roslin Institute has successfully created pigs that are resistant to the highly contagious and often fatal disease.
The gene-edited animals proved immune to classical swine fever (CSF), which causes fever, skin lesions, convulsions, diarrhoea, and often death within 15 days. In contrast, control pigs exposed to CSF developed symptoms of the disease and had high levels of the virus in their blood. The research team monitored several generations of gene-edited pigs and found no adverse effects on health or fertility.
Classical swine fever has been a major threat to pig farming globally, with periodic outbreaks leading to costly vaccination programs, international trade restrictions, and even culling of thousands of pigs. In the UK alone, 75,000 pigs were culled after an outbreak in the 1960s. The disease is also endemic in countries such as China, Russia, and Brazil.
The breakthrough comes at a time when many countries are relaxing rules around gene editing in agriculture, with the UK's Precision Breeding Act paving the way for gene-edited crops. Genus, a company based in Basingstoke, has already generated pigs that are resistant to a virus causing porcine reproductive and respiratory syndrome.
The research team believes that their findings have significant implications for animal welfare and productivity. "This virus has a severe effect on animal welfare and productivity," said Dr Christine Tait-Burkard, a group leader at the Roslin Institute. The team is now investigating whether the same gene edit can confer resistance to similar diseases in other species.
The development of disease-resistant pigs could help bolster the resilience of the livestock sector to CSF and other viral diseases. "In my mind there is a moral imperative that if we can make animals that are disease resistant then we probably should do," said Dr Simon Lillico, research scientist at the Roslin Institute.
The breakthrough has been hailed as a major step forward in using genomics-enabled innovation to build resilience to disease in livestock populations. "Decades of genomic research have made it possible to pinpoint and precisely edit the genes involved in disease resistance," said Dr Emily Clark of EMBL's European Bioinformatics Institute.
The gene-edited animals proved immune to classical swine fever (CSF), which causes fever, skin lesions, convulsions, diarrhoea, and often death within 15 days. In contrast, control pigs exposed to CSF developed symptoms of the disease and had high levels of the virus in their blood. The research team monitored several generations of gene-edited pigs and found no adverse effects on health or fertility.
Classical swine fever has been a major threat to pig farming globally, with periodic outbreaks leading to costly vaccination programs, international trade restrictions, and even culling of thousands of pigs. In the UK alone, 75,000 pigs were culled after an outbreak in the 1960s. The disease is also endemic in countries such as China, Russia, and Brazil.
The breakthrough comes at a time when many countries are relaxing rules around gene editing in agriculture, with the UK's Precision Breeding Act paving the way for gene-edited crops. Genus, a company based in Basingstoke, has already generated pigs that are resistant to a virus causing porcine reproductive and respiratory syndrome.
The research team believes that their findings have significant implications for animal welfare and productivity. "This virus has a severe effect on animal welfare and productivity," said Dr Christine Tait-Burkard, a group leader at the Roslin Institute. The team is now investigating whether the same gene edit can confer resistance to similar diseases in other species.
The development of disease-resistant pigs could help bolster the resilience of the livestock sector to CSF and other viral diseases. "In my mind there is a moral imperative that if we can make animals that are disease resistant then we probably should do," said Dr Simon Lillico, research scientist at the Roslin Institute.
The breakthrough has been hailed as a major step forward in using genomics-enabled innovation to build resilience to disease in livestock populations. "Decades of genomic research have made it possible to pinpoint and precisely edit the genes involved in disease resistance," said Dr Emily Clark of EMBL's European Bioinformatics Institute.